The incidence of left ventricular (LV) thrombus following acute myocardial infarction has
markedly declined in recent decades caused by advancements in reperfusion and …

Importance Left ventricular (LV) thrombus is a complication of acute myocardial infarction
(MI) and is associated with systemic thromboembolism. With randomized clinical trials …

Background Contemporary data are lacking regarding the prognosis and management of
left ventricular thrombus (LVT). Objectives The purpose of this study was to quantify the …

Aim Current guidelines recommend the use of vitamin K antagonist (VKA) for up to 3–6
months for treatment of left ventricular (LV) thrombus post-acute myocardial infarction (AMI) …

Aims Current guidelines recommend anticoagulation with a vitamin K antagonist to treat left
ventricular (LV) thrombus after myocardial infarction (MI). Data on the use of direct oral …

Left ventricular thrombus (LVT) is a serious complication of acute myocardial infarction (MI)
and also non-ischemic cardiomyopathies. We performed a narrative literature review …

Aims Left ventricular (LV) thrombus is increasingly detected in patients with and without
ischaemic heart disease due to the increased availability of cardiac magnetic resonance …

Left ventricular thrombosis (LVT) is a major risk factor for systemic thromboembolism and
might complicate both the acute and the chronic phase of ischaemic heart disease after …

Background Left ventricular thrombus (LVT) is not uncommon and pose a risk of systemic
embolism, which can be mitigated by adequate anticoagulation. Direct oral anticoagulants …

Left ventricular thrombus (LVT) complicates both ischemic and non-ischemic
cardiomyopathies and is a potential cause of thromboembolic complications such as stroke …